Lv41
570 积分 2024-02-03 加入
Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
9个月前
已完结
Signalling in pancreatic cancer: from pathways to therapy
9个月前
已完结
Breaking the stromal barrier in pancreatic cancer: Advances and challenges
10个月前
已完结
Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone
11个月前
已完结
ZNF263 cooperates with ZNF31 to promote the drug resistance and EMT of pancreatic cancer through transactivating RNF126
11个月前
已完结
Cancer-associated fibroblasts suppress ferroptosis and induce gemcitabine resistance in pancreatic cancer cells by secreting exosome-derived ACSL4-targeting miRNAs
11个月前
已关闭
Cancer‐associated fibroblasts promote stemness maintenance and gemcitabine resistance via HIF‐1α/miR‐21 axis under hypoxic conditions in pancreatic cancer
11个月前
已完结
N 6-methyladenosine Modification of FZR1 mRNA Promotes Gemcitabine Resistance in Pancreatic Cancer
11个月前
已完结
Gemcitabine effects on tumor microenvironment of pancreatic ductal adenocarcinoma: Special focus on resistance mechanisms and metronomic therapies
11个月前
已完结
Gemcitabine: A Review of Chemoresistance in Pancreatic Cancer
1年前
已完结
皖公网安备34019202002308
